Common use of Working across interfaces Clause in Contracts

Working across interfaces. The screening programme is dependent on strong working relationships (both formal and informal) between professionals and organisations along the screening pathway. These include maternity services, the screening and PND laboratories, SCT counselors, health visiting and specialist haematology clinical services. Accurate and timely communication and handover across these interfaces is essential to reduce the potential for errors and ensure a seamless pathway for service users. It is essential that there remains clear named clinical responsibility at all times and at handover of care the clinical responsibility is clarified. The provider will be responsible for ensuring that the pathway is robust. For their part the Provider will ensure that appropriate systems are in place to support an interagency approach to the quality of the interface between these services. This will include, but is not limited to:  ensuring that midwives are supported to facilitate early booking for maternity care within all care settings  agreeing and documenting roles and responsibilities relating to all elements of the screening pathway across organisations  providing strong clinical and managerial leadership and clear lines of accountability  developing joint audit and monitoring processes  working to nationally agreed Programme standards and policies  agreeing jointly on what failsafe mechanisms are required to ensure safe and timely processes across the whole screening pathway  contribute to any NHS England Screening Lead’s initiatives in screening pathway development in line with NHS Screening Programmes expectations  develop an escalation process for screening incidents (SIs)  facilitate education and training both inside and outside the provider organisation  Newborn laboratory and care services should be guided by The National Haemoglobinopathies Project: A Guide to Effectively Commissioning High Quality Sickle Cell and Thalassaemia Services and Specification for Specialised Services for Haemoglobinopathy Care (All Ages) (B08/S/a) xxxx://xxx.xxxxxxx.xxx.xx/wp- content/uploads/2013/06/b08-speci-serv-haemo.pdf

Working across interfaces. The screening programme is dependent on strong working relationships (both formal and informal) between professionals and organisations along the screening pathway. These include maternity services, the screening and PND laboratories, SCT counselorscounsellors, health visiting and specialist haematology clinical services. Accurate and timely communication and handover across these interfaces is essential to reduce the potential for errors and ensure a seamless pathway for service users. It is essential that there remains clear named clinical responsibility at all times and at handover of care the clinical responsibility is clarified. The provider will be responsible for ensuring that the pathway is robust. For their part the Provider provider will ensure that appropriate systems are in place to support an interagency approach to the quality of the interface between these services. This will include, but is not limited to:  • ensuring that midwives are supported to facilitate early booking for maternity care within all care settings  • agreeing and documenting roles and responsibilities relating to all elements of the screening pathway across organisations  • providing strong clinical and managerial leadership and clear lines of accountability  • developing joint audit and monitoring processes  • working to nationally agreed Programme programme standards and policies  • agreeing jointly on what failsafe mechanisms are required to ensure safe and timely processes across the whole screening pathway  and implement checks and audits to improve quality and reduce risks • contribute to any NHS England E Screening Lead’s initiatives in screening pathway development in line with NHS Screening Programmes expectations  expectations‌‌‌‌ • develop an escalation process for screening safety incidents (SIs)  facilitate education and training both inside and outside the provider organisation  Newborn laboratory and care services should be guided by • The National Haemoglobinopathies Project: A Guide to Effectively Commissioning High Quality Sickle Cell and Thalassaemia Services and Specification for Specialised Services for Haemoglobinopathy Care (All Ages) (B08/S/a) xxxx://xxx.xxxxxxx.xxx.xx/wp- content/uploads/2013/06/b08-speci-serv-haemo.pdfin development). Treatment services are under review, however this will have no impact on the screening care pathway. It will be published at: xxxxx://xxx.xxxxxxx. xxx.xx/xxxxxxxxxxxxx/xxxx-xxxxxxxx/xxx-xxx/xxxxx-xxx-xxxxxxxxx-xxxxx-x/x00/

Working across interfaces. The screening programme is dependent on strong working relationships (both formal and informal) between the professionals and organisations along involved in the screening pathway. These include maternity services, the screening and PND laboratories, SCT counselors, health visiting and specialist haematology clinical services. Accurate and timely communication and handover across these interfaces is are essential to reduce the potential for errors and ensure a seamless pathway for service users. It is essential that there remains clear named clinical responsibility at all times and at handover of care the clinical responsibility is clarifiedtimes. The provider will be responsible for ensuring that the pathway is robustwell managed. For their part the Provider provider will ensure that appropriate systems are in place to support an interagency approach to the quality of the interface between these services. This will include, but is not limited to:  ensuring that midwives are supported to facilitate early booking for maternity care within all care settings  • agreeing and documenting roles and responsibilities relating to all elements of the screening pathway across organisations  • providing strong clinical and managerial leadership and clear lines of accountability  • developing joint audit and monitoring processes  • working to nationally agreed Programme programme standards and policies  • agreeing jointly on what failsafe mechanisms are required to ensure safe and timely processes across the whole screening pathway  contribute pathway, see Checks and audits failsafe procedures • contributing to any NHS England Screening Lead’s and NHS Improvement initiatives in screening pathway development in line with NHS Screening Programmes screening programmes expectations  • develop an escalation process for screening safety incidents (SIs)  • facilitate education and training both inside and outside the provider organisation  Interface is where: • midwife notifies a new birth and NHS number is issued, automatic notification to local CHRD usually but must be able to receive hard and electronic copy from independent/community midwives via post/generic NHSmail account • set of approved barcoded NHS number baby labels printed and placed in PCHR • maternity staff responsible for care send blood spot card to newborn screening laboratory with the barcoded NHS number label, and all fields on the card completed with four good quality blood spots. If screening is declined the completed card should still be sent to the laboratory with the blood spots section blank • Newborn Blood Spot Failsafe Solution (NBSFS) is used to confirm laboratory receipt of sample and all results recorded (status codes and subcodes used) • laboratory requests midwifery services for a repeat (this will include where NHS number is missing), this can be via the NBSFS when enabled • laboratory sends results to Child Health Record Department and NBSFS, using screening status results codes and subcodes and ideally electronically • Child Health Record Department checks for untested babies within effective timeframe, all babies over 14 (17) days and 365 days are checked • NBSFS highlights to maternity services babies where there is no sample received, repeat required or results not complete • laboratory refers screen positive results to specialist teams • laboratory communicates carrier screening results via locally agreed pathway • specialist teams report, to the newborn screening laboratory, diagnostic tests/ outcome result • Child Health Record Department send screen negative results letter to health visiting services (or agreed alternative) and to parents. This principle applies to babies where all nine results are negative and it applies for babies where one result is suspected or the baby is too old for CF. xxxxx://xxx.xxx.xx/government/ publications/newborn-blood-spot-screening-results-to-parents-template‌‌ • Child Health Record Department informs maternity or health visiting services of missing results • midwife/health visitor perform screening for movers in so that Child Health Record Department can record conclusive results on the child health information system (CHIS) within 21 calendar days of recording the mover in on CHIS • the health care services professional responsible for screening informs CHRD if unable to complete screen or screening declined so it can be recorded on the baby’s record. This is in addition to sending a completed card to the laboratory writing ‘declined’ where the spots should be guided • health visiting services (or agreed alternative) ensure parents receive results and record results in PCHR by The National Haemoglobinopathies Project: A Guide 6 weeks • a process for safely communicating all results if baby has a ‘suspected’ or ‘carrier’ result and helping parents to Effectively Commissioning High Quality Sickle Cell access further information and Thalassaemia Services and Specification for Specialised Services for Haemoglobinopathy support when necessary In addition, see 2.2 Care (All Ages) (B08/S/a) xxxx://xxx.xxxxxxx.xxx.xx/wp- content/uploads/2013/06/b08-speci-serv-haemo.pdfpathway.

Working across interfaces. The screening programme is dependent on strong working relationships (both formal and informal) between professionals and organisations along the screening pathway. These include maternity services, the screening and PND laboratories, SCT counselorscounsellors, health visiting and specialist haematology clinical services. Accurate and timely communication and handover across these interfaces is essential to reduce the potential for errors and ensure a seamless pathway for service users. It is essential that there remains clear named clinical responsibility at all times and at handover of care the clinical responsibility is clarified. The provider will be responsible for ensuring that the pathway is robust. For their part the Provider provider will ensure that appropriate systems are in place to support an interagency approach to the quality of the interface between these services. This will include, but is not limited to:  ensuring that midwives are supported to facilitate early booking for maternity care within all care settings  agreeing and documenting roles and responsibilities relating to all elements of the screening pathway across organisations  providing strong clinical and managerial leadership and clear lines of accountability  developing joint audit and monitoring processes  working to nationally agreed Programme programme standards and policies  agreeing jointly on what failsafe mechanisms are required to ensure safe and timely processes across the whole screening pathway  contribute to any NHS England E Screening Lead’s initiatives in screening pathway development in line with NHS Screening Programmes expectations  develop an escalation process for screening safety incidents (SIs)  facilitate education and training both inside and outside the provider organisation  Newborn newborn laboratory and care services should be guided by The National Haemoglobinopathies Project: A Guide to Effectively Commissioning High Quality Sickle Cell and Thalassaemia Services and Specification for Specialised Services for Haemoglobinopathy Care (All Ages) (B08/S/a) xxxx://xxx.xxxxxxx.xxx.xx/wp- content/uploads/2013/06/b08-speci-serv-haemo.pdf